
Christopher W. Fulton
Examiner (ID: 16699, Phone: (571)272-2242 , Office: P/2855 )
| Most Active Art Unit | 2855 |
| Art Unit(s) | 2859, 3641, 2406, 2899, 2841, 2855, 3108, 2856 |
| Total Applications | 3373 |
| Issued Applications | 2875 |
| Pending Applications | 85 |
| Abandoned Applications | 419 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6468041
[patent_doc_number] => 20100040664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-18
[patent_title] => 'AABB-POLY(DEPSIPEPTIDE) BIODEGRADABLE POLYMERS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/540285
[patent_app_country] => US
[patent_app_date] => 2009-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15317
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20100040664.pdf
[firstpage_image] =>[orig_patent_app_number] => 12540285
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/540285 | AABB-POLY(DEPSIPEPTIDE) BIODEGRADABLE POLYMERS AND METHODS OF USE | Aug 11, 2009 | Abandoned |
Array
(
[id] => 10121350
[patent_doc_number] => 09155696
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-13
[patent_title] => 'Pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 13/058074
[patent_app_country] => US
[patent_app_date] => 2009-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6607
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13058074
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/058074 | Pharmaceutical compositions | Aug 10, 2009 | Issued |
Array
(
[id] => 6222366
[patent_doc_number] => 20100056432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'TEMPLATE-FIXED PEPTIDOMIMETICS WITH ANTIBACTERIAL ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 12/506794
[patent_app_country] => US
[patent_app_date] => 2009-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50251
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0056/20100056432.pdf
[firstpage_image] =>[orig_patent_app_number] => 12506794
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/506794 | TEMPLATE-FIXED PEPTIDOMIMETICS WITH ANTIBACTERIAL ACTIVITY | Jul 20, 2009 | Abandoned |
Array
(
[id] => 11508451
[patent_doc_number] => 09599603
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-21
[patent_title] => 'Methods and compositions for modulating adhesion and migration of cadherin expressing cells'
[patent_app_type] => utility
[patent_app_number] => 12/504578
[patent_app_country] => US
[patent_app_date] => 2009-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 13991
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12504578
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/504578 | Methods and compositions for modulating adhesion and migration of cadherin expressing cells | Jul 15, 2009 | Issued |
Array
(
[id] => 5315952
[patent_doc_number] => 20090280550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-12
[patent_title] => 'Polymer-Factor IX Moiety Conjugates'
[patent_app_type] => utility
[patent_app_number] => 12/499770
[patent_app_country] => US
[patent_app_date] => 2009-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22618
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20090280550.pdf
[firstpage_image] =>[orig_patent_app_number] => 12499770
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/499770 | Polymer-Factor IX Moiety Conjugates | Jul 7, 2009 | Abandoned |
Array
(
[id] => 9777691
[patent_doc_number] => 08852895
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-07
[patent_title] => 'Macrocyclic derivative and assemblies formed therefrom'
[patent_app_type] => utility
[patent_app_number] => 13/002067
[patent_app_country] => US
[patent_app_date] => 2009-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 17476
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13002067
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/002067 | Macrocyclic derivative and assemblies formed therefrom | Jul 5, 2009 | Issued |
Array
(
[id] => 6306384
[patent_doc_number] => 20100069294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'HCV PROTEASE INHIBITORS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/497103
[patent_app_country] => US
[patent_app_date] => 2009-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 56701
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20100069294.pdf
[firstpage_image] =>[orig_patent_app_number] => 12497103
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/497103 | HCV protease inhibitors and uses thereof | Jul 1, 2009 | Issued |
Array
(
[id] => 5496339
[patent_doc_number] => 20090264367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => '5-CNAC AS ORAL DELIVERY AGENT FOR PARATHYROID HORMONE FRAGMENTS'
[patent_app_type] => utility
[patent_app_number] => 12/495966
[patent_app_country] => US
[patent_app_date] => 2009-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3140
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20090264367.pdf
[firstpage_image] =>[orig_patent_app_number] => 12495966
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/495966 | 5-CNAC AS ORAL DELIVERY AGENT FOR PARATHYROID HORMONE FRAGMENTS | Jun 30, 2009 | Abandoned |
Array
(
[id] => 5496459
[patent_doc_number] => 20090264487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'HEMIASTERLIN ANALOGS'
[patent_app_type] => utility
[patent_app_number] => 12/491839
[patent_app_country] => US
[patent_app_date] => 2009-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8237
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20090264487.pdf
[firstpage_image] =>[orig_patent_app_number] => 12491839
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/491839 | HEMIASTERLIN ANALOGS | Jun 24, 2009 | Abandoned |
Array
(
[id] => 8177618
[patent_doc_number] => 08178651
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-15
[patent_title] => 'Somatostatin-dopamine chimeric analogs'
[patent_app_type] => utility
[patent_app_number] => 12/456715
[patent_app_country] => US
[patent_app_date] => 2009-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9189
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/178/08178651.pdf
[firstpage_image] =>[orig_patent_app_number] => 12456715
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/456715 | Somatostatin-dopamine chimeric analogs | Jun 21, 2009 | Issued |
Array
(
[id] => 6479844
[patent_doc_number] => 20100092500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'NOVEL IMMUNOGENIC LIPOPEPTIDES COMPRISING T-HELPER AND B-CELL EPITOPES'
[patent_app_type] => utility
[patent_app_number] => 12/488485
[patent_app_country] => US
[patent_app_date] => 2009-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 31389
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20100092500.pdf
[firstpage_image] =>[orig_patent_app_number] => 12488485
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/488485 | Immunogenic lipopeptides comprising T-helper and B-cell epitopes | Jun 18, 2009 | Issued |
Array
(
[id] => 9951135
[patent_doc_number] => 08999923
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-07
[patent_title] => 'Heat-stable, aqueous lactoferrin composition and its preparation and use'
[patent_app_type] => utility
[patent_app_number] => 12/999292
[patent_app_country] => US
[patent_app_date] => 2009-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 5312
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12999292
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/999292 | Heat-stable, aqueous lactoferrin composition and its preparation and use | Jun 14, 2009 | Issued |
Array
(
[id] => 8896887
[patent_doc_number] => 08476408
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-02
[patent_title] => 'Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease'
[patent_app_type] => utility
[patent_app_number] => 12/482882
[patent_app_country] => US
[patent_app_date] => 2009-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 14179
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12482882
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/482882 | Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease | Jun 10, 2009 | Issued |
Array
(
[id] => 5484893
[patent_doc_number] => 20090274658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'Tight Junction Modulating Peptides for Enhanced Mucosal Delivery of Therapeutic Compounds'
[patent_app_type] => utility
[patent_app_number] => 12/480519
[patent_app_country] => US
[patent_app_date] => 2009-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15152
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20090274658.pdf
[firstpage_image] =>[orig_patent_app_number] => 12480519
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/480519 | Tight Junction Modulating Peptides for Enhanced Mucosal Delivery of Therapeutic Compounds | Jun 7, 2009 | Abandoned |
Array
(
[id] => 5465114
[patent_doc_number] => 20090325314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'N-Methyl Scanning Mutagenesis'
[patent_app_type] => utility
[patent_app_number] => 12/479331
[patent_app_country] => US
[patent_app_date] => 2009-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3142
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12479331
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/479331 | N-Methyl Scanning Mutagenesis | Jun 4, 2009 | Abandoned |
Array
(
[id] => 9099810
[patent_doc_number] => 08563689
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2013-10-22
[patent_title] => 'Methods for regulating inflammatory mediators and peptides for useful therein'
[patent_app_type] => utility
[patent_app_number] => 12/478491
[patent_app_country] => US
[patent_app_date] => 2009-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 24
[patent_no_of_words] => 22979
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12478491
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/478491 | Methods for regulating inflammatory mediators and peptides for useful therein | Jun 3, 2009 | Issued |
Array
(
[id] => 10115737
[patent_doc_number] => 09150609
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-06
[patent_title] => 'Process for the preparation of copolymer-1 using a polymer supported dialkylamine initiator'
[patent_app_type] => utility
[patent_app_number] => 13/375914
[patent_app_country] => US
[patent_app_date] => 2009-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3271
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13375914
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/375914 | Process for the preparation of copolymer-1 using a polymer supported dialkylamine initiator | Jun 3, 2009 | Issued |
Array
(
[id] => 8797271
[patent_doc_number] => 08436140
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-07
[patent_title] => 'Natriuretic peptide-mediated imaging of atherosclerotic plaque'
[patent_app_type] => utility
[patent_app_number] => 12/454810
[patent_app_country] => US
[patent_app_date] => 2009-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 25
[patent_no_of_words] => 8656
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12454810
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/454810 | Natriuretic peptide-mediated imaging of atherosclerotic plaque | May 21, 2009 | Issued |
Array
(
[id] => 6120766
[patent_doc_number] => 20110077190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-31
[patent_title] => 'Selective Caspase Inhibitors and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/993565
[patent_app_country] => US
[patent_app_date] => 2009-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29793
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20110077190.pdf
[firstpage_image] =>[orig_patent_app_number] => 12993565
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/993565 | Selective caspase inhibitors and uses thereof | May 20, 2009 | Issued |
Array
(
[id] => 7682059
[patent_doc_number] => 20100022749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'Contoxin Analogues and Methods for Synthesizing Same'
[patent_app_type] => utility
[patent_app_number] => 12/469503
[patent_app_country] => US
[patent_app_date] => 2009-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 54693
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20100022749.pdf
[firstpage_image] =>[orig_patent_app_number] => 12469503
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/469503 | Contoxin analogues and methods for synthesizing same | May 19, 2009 | Issued |